Financial Advocates Investment Management raised its stake in shares of iShares Russell 1000 Growth ETF (NYSEARCA:IWF – Free Report) by 122.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 17,914 shares of the exchange traded fund’s stock after buying an additional 9,849 […]
Financial Advocates Investment Management lowered its holdings in shares of Vanguard Dividend Appreciation ETF (NYSEARCA:VIG – Free Report) by 3.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 37,160 shares of the company’s stock after selling 1,166 shares during the period. Financial Advocates […]
Financial Advocates Investment Management decreased its holdings in shares of iShares Core S&P Small-Cap ETF (NYSEARCA:IJR – Free Report) by 5.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 66,197 shares of the exchange traded fund’s stock after selling 3,913 […]
Financial Advocates Investment Management lessened its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 1.5% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 32,844 shares of the company’s stock after selling 507 shares during the quarter. Financial Advocates Investment Management’s holdings in AbbVie were worth $5,090,000 […]
Financial Advocates Investment Management acquired a new position in iShares Global Tech ETF (NYSEARCA:IXN – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 49,264 shares of the company’s stock, valued at approximately $3,359,000. Financial Advocates Investment Management […]